Bcl-1/cyclin D1 in malignant lymphoma

Annals of Oncology

Volumn 8, Issue SUPPL. 2, 1997, Pages

  De Boer, C J ^a   Van Krieken, J H J M ^a   Schuuring, E ^a   Kluin, P M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

11 q13; Bcl 1; Centrocytic lymphoma; Cyclin D1; Hairy cell leukemia; Mantle cell lymphoma; Review; T(11; 14)

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENTARY DNA; CYCLIN D1; DNA; GLYCOGEN PHOSPHORYLASE; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN D; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M; MESSENGER RNA; MONOCLONAL ANTIBODY KI 67; PEPSINOGEN; PROTEIN P16; PROTEIN P53; PURINE; PYRIMIDINE; RECOMBINASE; RNA; TRANSFERASE;

CARCINOGENESIS; CHROMOSOME TRANSLOCATION; CONFERENCE PAPER; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DELETION; HAIRY CELL LEUKEMIA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA; MANTLE CELL LYMPHOMA; NORTHERN BLOTTING; ONCOGENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR GROWTH;

EID: 0030840849     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/8.suppl_2.s109     Document Type: Conference Paper

References (145)

1. Gerard-Marchant R, Hamlin I, Lennert K et al. Classification of non-Hodgkin's lymphoma. Lancet 1974; 2: 406-8.
2. Berard CW, Dorfman RF. Histopathology of malignant lymphomas. Clin Haematol 1974; 3: 39-76.
3. Weisenburger DD, Kim H, Rappaport H. Mantle-zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma. Cancer 1982; 49: 1429-38.
4. Weisenburger DD. Mantle-zone lymphoma: An immunohistologic study. Cancer 1984; 53: 1073-80.
5. Jaffe ES, Bookman MA, Longo DL. Lymphocytic lymphoma of intermediate differentiation-mantle zone lymphoma: A distinct subtype of B-cell lymphoma. Hum Pathol 1987; 18: 877-80.
6. Lukes RJ, Collins RD. New approaches to the classification of the lymphomata. Br J Cancer 1975; 31 (Suppl): 1-12.
7. The Non-Hodgkin's Lymphoma Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphoma: Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112-35.
8. Raffeld M, Jaffe ES. BCL-1, t(11;14), and mantle cell derived lymphomas. Blood 1991; 78: 259-63.
9. Raffeld M, Sander CA, Yano T et al. Mantle cell lymphoma: An update. Leuk Lymph 1992; 8: 161-6.
10. Weisenburger DD, Chan WC. Lymphomas of follicles: Mantle cell and follicule center cell lymphomas. Am J Clin Pathol 1993; 99: 409-20.
11. Banks PM, Chan J, Cleary ML et al. Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 1992; 16: 637-40.
12. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
13. Zucca E, Stein H, Coiffier B (European Lymphoma Task Force [ELTF]). Report of the workshop on mantle cell lymphoma (MCL). Ann Oncol 1994; 5: 507-11.
14. Weisenburger DD. Mantle cell lymphoma. Neopl Hematopathol 1992; 617-28.
15. Velders GA, Kluin-Nelemans JC, De Boer CJ et al. Mantle cell lymphoma: A population based clinical study. J Clin Oncol 1995; 14: 1269-74.
16. Shivdasani RA, Hess JL, Skarin AT et al. Intermediate lymphocytic lymphoma: Clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma. J Clin Oncol 1993; 11: 802-11.
17. Berger F, Felman P, Sonet A et al. Nonfollicular small B-cell lymphomas: A heterogeneous group of patients with distinct clinical features and outcome. Blood 1994; 83: 2829-35.
18. Cornes JS. Multiple lymphomatous polyposis of the gastro-intestinal tract. Cancer 1961; 14: 249-57.
19. Moynihan MJ, Bast MA, Chan WC et al. Lymphomatous polyposis: A neoplasm of either follicular mantle or germinal center cell origin. Am J Surg Pathol 1996; 20: 442-52.
20. O'Brien DS, Kennedy MJ, Daly PA et al. Multiple lymphomatous polyposis of the gastrointestinal tract. Am J Surg Pathol 1989; 13: 691-9.
21. Pals ST, Drillenburg P, Dragosics B et al. Expression of the mucosal homing receptor α4β7 in malignant lymphomatous polyposis of the intestine. Gastroenterology 1994; 107: 1519-23.
22. Zucca E, Fontana S, Roggero E et al. Treatment and prognosis of centrocytic (mantle cell) lymphoma: A retrospective analysis of twenty-six patients treated in one institution. Leuk Lymph 1994; 13: 105-10.
23. Pittaluga S, Wlodarska I, Stul MS et al. Mantle cell lymphoma: A clinicopathological study of 55 cases. Histopathology 1995; 26: 17-24.
24. Segal GH, Masih AS, Canavan Fox A et al. CDS-expressing B-cell non-Hodgkin's lymphomas with BCL-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Blood 1995; 85: 1570-9.
25. Fisher RI, Dahlberg S, Nathwani BN et al. A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories). A Southwest Oncology Group study. Blood 1995; 85: 1075-82.
26. Lardelli P, Bookman MA, Sundeen J et al. Lymphocytic lymphoma of intermediate differentiation. Am J Surg Pathol 1990; 14: 752-63.
27. Norton AJ, Matthews J, Pappa V et al. Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period. Ann Oncol 1995; 6: 249-56.
28. Zucca E, Roggero E, Pinotti G et al. Patterns of survival in mantle cell lymphoma. Ann Oncol 1995; 6: 257-62.
29. Stewart DA, Vose JM, Weisenburger DD et al. The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Ann Oncol 1995; 6: 263-6.
30. Ott MM, Ott G, Kuse R et al. The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the BCL-1 gene and high proliferation indices. Histopathology 1994; 24: 329-34.
31. Klein U, Küppers R, Rajewsky K. Human IgM+ IgD+ B-cells, the major B-cell subset in the peripheral blood, express Vh genes with no or little somatic mutation throughout life. Eur J Immunol 1993; 23: 3272-7.
32. Küppers R, Zhao M, Hansmann M et al. Tracing B-cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 1993; 12: 4955-67.
33. Ott MM, Helbing A, Ott G et al. BCL-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma. J Pathol 1996; 179: 238-42.
34. Stansfeld AC. Updated Kiel classification for lymphomas. Lancet 1988; 1: 292-3.
35. Daniel M, Tigaud I, Flexor M et al. Leukaemic non-Hodgkin's lymphomas with hyperdiploid cells and t(11;14)(q13;q32): A subtype of mantle cell lymphoma? Br J Haematol 1995; 90: 77-84.
36. Louie DC, Offit K, Jaslow R et al. P53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood 1995; 86: 2892-9.
37. Caligaris-Cappio F, Gobbi M, Bofill M et al. Infrequent normal B lymphocytes express features of B chronic lymphocytic leukemia. J Exp Med 1982; 155: 623-8.
38. Loyson S, De Boer CJ, Schuuring E et al. Mantle cell lymphoma: A morphological, immunohistochemical, and molecular genetic study. Path Res Pract 1996; 192: 1-11.
39. Verbunt RJAM, Den Ottolander GJ, Kluin PM et al. Circulating buttock cells in non-Hodgkin's lymphoma. Leukemia 1989; 3: 578-84.
40. Koduru PRK, Offit K, Filippa DA. Molecular analysis of breaks in BCL-1 proto-oncogene in B-cell lymphomas with abnormalities of 11q13. Oncogene 1989; 4: 929-34.
41. Tsujimoto Y, Yunis JJ, Onorato-Showe L et al. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 1984; 224: 1403-6.
42. Tsujimoto Y, Jaffe ES, Cossman J et al. Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 1985; 315: 340-3.
43. Rabbitts PH, Douglas J, Fischer PE et al. Chromosome abnormalities at 11q13 in B-cell tumours. Oncogene 1988; 3: 99-103.
44. Boehm T, Mengle-Gaw L, Kees UR et al. Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours. EMBO J 1989; 8: 2621-31.
45. Erikson J, Finan JB, Tsujimoto Y et al. The chromosome 14 breakpoint in neoplastic B cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus. Proc Natl Acad Sci USA 1984; 81: 4144-8.
46. Molot RJ, Meeker TC, Wittwer CT et al. Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas. Blood 1994; 83: 1626-31.
47. Luthra R, Hai S, Pugh WC. Polymerase chain reaction detection of the t(11;14) translocation involving the BCL-1 major translocation cluster in mantle cell lymphoma. Diag Mol Pathol 1995; 4: 4-7.
48. Williams ME, Swerdlow SH, Meeker TC. Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the BCL-1 major translocation cluster. Leukemia 1993; 7: 1437-40.
49. Rimokh R, Berger F, Delsol G et al. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 1994; 83: 1871-5.
50. Meeker TC, Sellers W, Harvey RC et al. Cloning of the t(11;14)-(q13;q32) translocation breakpoints from two human leukemia cell lines. Leukemia 1991; 5: 733-7.
51. Meeker TC, Grimaldi JC, O'Rourke R et al. An additional breakpoint region in the BCL-1 locus associated with the t(11;14)-(q13;q32) translocation of B-lymphocytic malignancy. Blood 1989; 74: 1801-6.
52. Rosenberg CL, Wong E, Petty EM et al. PRAD1, a candidate BCL-1 oncogene: Mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci 1991; 88: 9638-42.
53. Withers DA, Harvey RC, Faust JB et al. Characterization of a candidate BCL-1 gene. Mol Cell Biol 1991; 11: 4846-53.
54. Brookes S, Lammie GA, Schuuring E et al. Linkage map of a region of human chromosome band 11q13 amplified in breast and squamous cell tumors. Genes Chrom Cancer 1992; 4: 290-301.
55. De Boer CJ, Loyson S, Kluin PM et al. Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: Rearrangement of the cyclin D1 gene. Cancer Res 1993; 53: 4148-52.
56. Williams ME, Swerdlow SH, Rosenberg CL et al. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia 1993; 7: 241-5.
57. Motokura T, Arnold A. Cyclins and oncogenesis. Biochim Biophys Acta 1993; 1155: 63-78.
58. Vaandrager JW, Zwikstra E, De Boer CJ et al. Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multi-color DNA fiber FISH. Blood 1996; 88: 1177-82.
59. Vandenberghe E, De Wolf-Peeters C, Wlodarska I et al. Chromosome 11q rearrangements in B non Hodgkin's lymphoma. Br J Haematol 1992; 81: 212-7.
60. Yunis JJ. The chromosomal basis of human neoplasia. Science 1983; 221: 227-36.
61. Coignet LJA, Schuuring E, Kibbelaar RE et al. Detection of 11q13 rearrangements in hematologic neoplasias by double color fluorescence in situ hybridization. Blood 1996; 87: 1512-9.
62. Raynaud SD, Bekri S, Leroux D et al. Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies. Genes Chrom Cancer 1993; 8: 80-7.
63. Rimokh R, Berger F, Delsol G et al. Rearrangement and over-expression of the BCL-1/PRAD1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 1993; 81: 3063-7.
64. Newman RA, Peterson B, Davey FR et al. Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: A cancer and leukemia group B study. Blood 1993; 82: 1239-46.
65. Williams ME, Swerdlow SH, Rosenberg CL et al. Characterization of chromosome 11 translocation breakpoints at the BCL-1 and PRAD1 loci in centrocytic lymphoma. Cancer Res 1992; 52: 5541-4s.
66. Jadayel D, Matutes E, Dyer MJS et al. Splenic lymphoma with villous lymphocytes: Analysis of BCL-1 rearrangements and expression of the cyclin D1 gene. Blood 1994; 83: 3664-71.
67. Koduru PRK, Zairwala M, Soni M et al. Deletion of cyclin-dependent kinase 4 inhibitor genes p15 and p16 in non-Hodgkin's lymphoma. Blood 1995; 86: 2900-5.
68. Delmer A, Ajchenbaum-Cymbalista F, Tang R et al. Over-expression of cyclin D1 in chronic B-cell malignancies with abnormality of chromosome 11q13. Br J Haematol 1995; 89: 798-804.
69. Cuneo A, Balboni M, Piva N et al. Atypical chronic lymphocytic leukemia with t(11;14)(q13;q32): Karyotype evolution and prolymphocytic transformation. Br J Haematol 1995; 90: 409-16.
70. Weisenburger DD, Sanger WG, Armitage JO et al. Intermediate lymphocytic lymphoma: Immunophenotypic and cytogenetic findings. Blood 1987; 6: 1617-21.
71. Leroux D, Le Marc'Hadour F, Gressin R et al. Non-Hodgkin's lymphomas with t(11;14)(q13;q32): A subset of mantle zone/intermediate lymphocytic lymphoma? Br J Haematol 1991; 77: 346-53.
72. Williams ME, Westermann CD, Swerdlow SH. Genotypic characterization of centrocytic lymphoma: Frequent rearrangement of the chromosome 11 BCL-1 locus. Blood 1990; 76: 1387-91.
73. Williams ME, Meeker TC, Swerdlow SH. Rearrangement of the chromosome 11 BCL-1 locus in centrocytic lymphoma: Analysis with multiple breakpoint probes. Blood 1991; 78: 493-8.
74. Medeiros LJ, Van Krieken JHJM, Jaffe ES et al. Association of BCL-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood 1990; 76: 2086-90.
75. Rimokh R, Berger F, Cornillet P et al. Break in the BCL-1 locus is closely associated with intermediate lymphocytic lymphoma subtype. Genes Chrom Cancer 1990; 2: 223-6.
76. Ott MM, Müller-Hermelink HK, Schmitt B et al. Chromosomal translocation detected by BCL-1 and BCL-2 rearrangement in low-grade B-cell lymphomas in a European population. Histopathology 1991; 19: 163-7.
77. Hayashi T, Ohno H, Yamabe H et al. Clinical aspects of B-cell malignancy involving the BCL-1/PRAD1 locus. Int J Hem 1994; 59: 281-96.
78. Peters G. The D-type cyclins and their role in tumorigenesis. J Cell Sci 1994; 18 (Suppl): 89-96.
79. Lammie GA, Peters G. Chromosome 11q13 abnormalities in human cancer. Cancer Cells 1991; 3: 413-20.
80. Arnold A, Kim H, Gaz RD et al. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 1989; 83: 2034-40.
81. Rosenberg CL, Kim H, Shows TB et al. Rearrangement and over-expression of D1IS287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 1991; 6: 449-53.
82. Xiong Y, Connolly T, Futcher B et al. Human D-type cyclin. Cell 1991; 65: 691-9.
83. Lew DJ, Dulic V, Reed SI. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 1991; 66: 1197-206.
84. Schuuring E, Verhoeven E, Mooi WJ et al. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 1992; 7: 355-61.
85. Hirama T, Koeffler HP. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995; 86: 841-54.
86. Schuuring E. The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes. Gene 1995; 159: 83-96.
87. Seto M, Yamamoto K, Iida S et al. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)-(q13;q32) translocation. Oncogene 1992; 7: 1401-6.
88. Lukas J, Jadayel D, Bartkova J et al. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation. Oncogene 1994; 9: 2159-67.
89. De Boer CJ, Van Krieken JHJM, Kluin-Nelemans JC et al. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene 1995; 10: 1833-40.
90. Akiyama N, Tsuruta H, Sasaki H et al. Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32). Cancer Res 1994; 54: 377-9.
91. Williams ME, Swerdlow SH. Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 BCL-1 rearrangement. Ann Oncol 1994; 5 (Suppl): S71-3.
92. Oka K, Ohno T, Kita K et al. PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphomas. Br J Haematol 1994; 86: 786-91.
93. Bosch F, Jares P, Campo E et al. PRAD1/cyclin D1 gene over-expression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma. Blood 1994; 84: 2726-32.
94. De Boer CJ, Schuuring E, Dreef E et al. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 1995; 86: 2715-23.
95. Yang WI, Zukerberg LR, Motokura T et al. Cyclin D1 (BCL-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994; 145: 86-96.
96. Zukerberg LR, Yang WI, Arnold A et al. Cyclin D1 expression in non-Hodgkin's lymphoma. Am J Clin Pathol 1995; 103: 756-60.
97. Bartkova J, Lukas J, Strauss M et al. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein. J Pathol 1994; 172: 237-45.
98. Swerdlow SH, YangWI, Zukerberg LR et al. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. Hum Pathol 1995; 26: 999-1004.
99. Rimokh R, Berger F, Bastard C et al. Rearrangement of CCND1 (BCL1/PRAD1) 3′ untranslated region in mantle cell lymphomas and t(11q13)-associated leukemias. Blood 1994; 83: 3689-96.
100. Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986; 46: 659-67.
101. Savant-Bhonsale S, Cleveland DW. Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a > 20S degradation complex. Genes Dev 1992; 6: 1927-39.
102. Zubiaga AM, Belasco JG, Greenberg ME. The nonamer UUAU-UUAUU is the key AU-rich sequence motif that mediates the mRNA degradation. Mol Cell Biol 1995; 15: 2219-30.
103. Komatsu H, Lida S, Yamamoto K et al. A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene. Blood 1994; 84: 1226-31.
104. Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L et al. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene 1994; 9: 1925-9.
105. Bates S, Parry D, Bonetta L et al. Absence of cyclin D/CDK complexes in cells lacking functional retinoblastoma protein. Oncogene 1994; 9: 1633-40.
106. Sewing A, Bürger C, Brüsselbach S et al. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J Cell Sci 1993; 104: 545-54.
107. 34PSK-J3/cdk4) for mammalian D-type G1 cyclins. Cell 1992; 71: 323-34.
108. Galiègue-Zouitina S, Collyn-d'Hooge M, Denis C et al. Molecular cloning of a t(11;14)(q13;q32) translocation breakpoint centromeric to the BCL1-MTC. Genes Chrom Cancer 1994; 11: 246-55.
109. Bartkova J, Lukas J, Müller H et al. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994; 57: 353-61.
110. Lukas J, Pagano M, Staskova Z et al. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 1994; 9: 707-18.
111. Gillett C, Fantl V, Smith R et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54: 1812-7.
112. Zhang SY, Caamano J, Cooper F et al. Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 1994; 102: 695-8.
113. Michalides R, Van Veelen N, Hart A et al. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995; 55: 975-8.
114. Bartkova J, Lukas J, Strauss M et al. Cyclin D1 onoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995; 10: 775-8.
115. Bartkova J, Lukas J, Strauss M et al. The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer 1994; 58: 568-73.
116. De Boer CJ, Kluin-Nelemans JC, Dreef E et al. Involvement of the CCND1 gene in hairy cell leukemia. Ann Oncol 1996; 7: 251-6.
117. Bosch F, Campo E, Jares P et al. Increased expression of the PRAD-1/CCND1 gene in hairy-cell leukaemia. Br J Haematol 1995; 91: 1019-24.
118. Zucca E, Soldati G, Schlegelberger B et al. Detection of chromosome 11 alterations in blood and bone marrow by interphase cytogenetics in mantle cell lymphoma. Br J Haematol 1995; 89: 665-8.
119. Frizzera G, Sakurai M, Notohara K et al. t(11;14)(q13;q32) in B-cell lymphomas (intermediately differentiated lymphocytic and follicular). Am J Clin Pathol 1991; 95: 684-91.
120. Brito-Babapulle V, Ellis J, Matutes E et al. Translocation t(11;14)(q13;q32) in chronic lymphoid disorders. Genes Chrom Cancer 1992; 5: 158-65.
121. Vandenberghe E, De Wolf-Peeters C, Oord JV et al. Translocation t(11;14): A cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage. J Pathol 1991; 163: 13-8.
122. Nowell PC, Vonderheid EC, Besa E et al. The most common chromosome change in 86 chronic B-cell or T-cell tumors: A 14q32 translocation. Cancer Genet Cytogenet 1986; 19: 219-27.
123. Juliusson G, Friberg K, Gahrton G. Consistency of chromosomal aberrations in chronic B-lymphocytic leukemia. Cancer 1988; 62: 500-6.
124. Juliusson G, Robèrt K, Öst A et al. Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma. Blood 1985; 65: 134-41.
125. Ince C, Blick M, Lee M et al. BCL-1 gene rearrangements in B-cell lymphoma. Leukemia 1988; 2: 343-6.
126. Koduru PRK, Filippa DA, Richardson ME et al. Cytogenetic and histologic correlations in malignant lymphoma. Blood 1987; 69: 97-102.
127. Yunis JJ, Oken MM, Theologides A et al. Recurrent chromosomal defects are found in most patients with non-Hodgkin's lymphoma. Cancer Genet Cytogenet 1984; 13: 17-28.
128. Yunis JJ, Oken MM, Kaplan ME et al. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med 1982; 307: 1231-6.
129. Bloomfield CD, Arthur DC, Frizzera G et al. Nonrandom chromosome abnormalities in lymphoma. Cancer Res 1983; 43: 2975-84.
130. Nishida K, Taniwaki M, Misawa S et al. Nonrandom rearrangement of chromosome 14 at band q32.33 in human lymphoid malignancies with mature B-cell phenotype. Cancer Res 1989; 49: 1275-81.
131. Weh HJ, Gutensohn K, Selbach J et al. Karyotype in multiple myeloma and plasma cell leukaemia. Eur J Cancer 1993; 29A: 1269-73.
132. Fiedler W, Weh HJ, Hossfeld DK. Comparison of chromosome analysis and BCL-1 rearrangement in a series of patients with multiple myeloma. Br J Haematol 1992; 81: 58-61.
133. Dewald GW, Kyle RA, Hicks GA et al. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 1985; 66: 380-90.
134. Gould J, Alexanian R, Goodacre A et al. Plasma cell karyotype in multiple myeloma. Blood 1988; 71: 453-6.
135. Zhang X, Gaillard JP, Robillard N et al. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 1994; 83: 3654-63.
136. Juneja S, Lukeis R, Tan L et al. Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma: Non-random chromosomal abnormalities and histological correlations. Br J Haematol 1990; 76: 231-7.
137. Wotherspoon AC, Pan L, Diss TC et al. A genotypic study of low grade B-cell lymphomas, including lymphomas of mucosa associated lymphoid tissue (MALT). J Pathol 1990; 162: 135-40.
138. Rechavi G, Katzir N, Brok-Simoni F et al. A search for BCL-1, BCL-2 and c-MYC oncogene rearrangements in chronic lymphocytic leukemia. Leukemia 1989; 3: 57-60.
139. Athan ES, Foitl DR, Knowles DM. BCL-1 rearrangement: Frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin's lymphomas. Am J Pathol 1991; 138: 591-9.
140. Gaidano G, Newcomb EW, Gong JZ et al. Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia. Am J Pathol 1994; 144: 1312-9.
141. Ott MM, Dahlheimer K, Müller-Hermelink HK et al. Gene rearrangement of BCL-1 and BCL-2 is confined to distinct subgroups of high-grade malignant B-cell lymphomas. J Pathol 1993; 169: 303-7.
142. Van Krieken JHJM, Raffeld M, Raghoebier S et al. Molecular genetics of gastrointestinal non-Hodgkin's lymphomas: Unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas. Blood 1990; 76: 797-800.
143. Hey MM, Feller AC, Kirchner T et al. Genomic analysis of T-cell receptor and immunoglobulin antigen receptor genes and breakpoint cluster regions in gastrointestinal lymphomas. Hum Pathol 1990; 21: 1283-7.
144. Selvanayagam P, Goodacre A, Strong L et al. Alterations of BCL-1 oncogene in human multiple myeloma. AACR 28: 761987 (Abstr).
145. Paquette RL, Berenson J, Lichtenstein A et al. Oncogenes in multiple myeloma: Point mutation of N-ras. Oncogene 1990; 5: 1659-63.